TransAct Technologies Incorporated (Nasdaq: TACT) (“TransAct” or the
“Company”) today reported operating results for the third quarter ended
September 30, 2015, as summarized below:
|
Summary of 2015 Q3 Results (In millions, except per
share and percentage data)
|
|
|
|
|
|
Three Months Ended September 30,
|
|
|
|
|
2015
|
|
|
2014
|
Net sales
|
|
|
|
$
|
14.2
|
|
|
$
|
13.4
|
Gross profit
|
|
|
|
$
|
6.3
|
|
|
$
|
5.3
|
Gross margin
|
|
|
|
|
44.4%
|
|
|
|
39.5%
|
Operating income
|
|
|
|
$
|
1.6
|
|
|
$
|
0.1
|
EBITDA(1)(2)
|
|
|
|
$
|
1.9
|
|
|
$
|
0.4
|
Net income
|
|
|
|
$
|
1.0
|
|
|
$
|
0.1
|
Diluted earnings per share
|
|
|
|
$
|
0.13
|
|
|
$
|
0.01
|
|
|
|
|
|
|
|
|
Adjusted operating income(2)
|
|
|
|
$
|
1.6
|
|
|
$
|
0.4
|
Adjusted EBITDA(1)(2)
|
|
|
|
$
|
2.0
|
|
|
$
|
0.9
|
Adjusted net income(2)
|
|
|
|
$
|
1.0
|
|
|
$
|
0.3
|
Adjusted diluted earnings per share(2)
|
|
|
|
$
|
0.13
|
|
|
$
|
0.04
|
|
|
|
|
|
|
|
|
(1)
|
|
EBITDA is defined as net income before net interest expense, income
taxes, depreciation and amortization. A reconciliation of EBITDA to
net income, the most comparable Generally Accepted Accounting
Principles (“GAAP”) financial measure, can be found attached to this
release. Adjusted EBITDA is defined as net income before net
interest expense, income taxes, depreciation, amortization and
adjusted for share-based compensation and the impact of certain
legal fees and adjustments to accrued contingent consideration from
the Printrex acquisition as described later in this release. A
reconciliation of Adjusted EBITDA to net income, the most comparable
GAAP financial measure, can be found attached to this release.
|
(2)
|
|
Reconciliations of GAAP financial measures to corresponding non-GAAP
financial measures can be found attached to this release.
|
|
|
|
Bart Shuldman, Chairman and Chief Executive Officer of TransAct,
commented, “TransAct’s strong 2015 third quarter financial results
benefited from our focus on sales and the successful expansion of our
product portfolio to include more higher-margin products. The 6%
year-over-year increase in revenue and 490 basis point increase in gross
margin during the third quarter drove an over three-fold rise in
adjusted operating income and a doubling of Adjusted EBITDA over the
prior-year quarter. We again generated strong sales of our food safety
terminals and solid results in our domestic casino and gaming business
while continuing our efforts to aggressively control costs across the
enterprise. As we finish 2015 and plan for the year ahead, we believe
that TransAct has built a strong foundation for continued success.
“Our focus on sales in 2015 has allowed us to build momentum for the
AccuDate 9700 food rotation terminal and results from the third quarter
and year to date demonstrate the growing acceptance of this
industry-unique solution. Sales of our AccuDate terminals have become
more consistent in the past several months and we are now generating
revenue from the AccuDate 9700 nearly every day. Increasingly,
restaurant and foodservice operators recognize the AccuDate 9700 as a
must have for their operations as it brings new efficiencies and savings
to their back of house operations. Building on this success, we have
introduced our new AccuDate Pro, a comprehensive ‘restaurant assistant’
that provides us with several additional industry opportunities. In
addition, based on new market opportunities, we are also making progress
on the development of enhanced versions of the AccuDate Pro which will
leverage new capabilities to further optimize food safety and food prep
operations.
“In our casino and gaming business, we continue to deliver notable
results in the domestic market. Notwithstanding the still choppy
domestic slot machine sales environment, our domestic casino printer
sales grew 70% year over year in the third quarter based on the features
and reliability of our Epic™ ticket-in, ticket-out gaming printers
combined with our industry-leading support. Going forward, we see
additional opportunities to drive further market share growth and
benefit from an acceleration of Epicentral® installations. We have a
growing backlog of Epicentral installations that are expected to come
online over the next few quarters and we continue to see interest from
operators around the world for this innovative print and bonusing
solution.
“The lottery industry remains strong for TransAct, with 22%
year-over-year growth in the third quarter even as sales have returned
to more normalized levels following a very healthy start to the year.
While our historical customer in the lottery industry continues to rely
on our extremely reliable printing solution, we are beginning to drive
initial interest from other industry participants in this large, global
marketplace based on the recent introduction of our new Epic 3000
printer.”
Mr. Shuldman concluded, “Our successful efforts to transform our
business are now benefiting our financial results and driving increased
excitement and confidence for our future. We expect to further grow our
gross margin heading into 2016 as our sales mix will reflect increased
sales of higher-margin products such as the AccuDate line of food safety
terminals and our Epicentral bonusing system. The entire TransAct team
remains focused on our commitment to a year in which ‘It’s All About
Sales’ and we expect to see further benefit from these efforts over the
balance of 2015 and throughout 2016.”
Review of Balance Sheet and Capital Return Initiatives
As of September 30, 2015, TransAct had approximately $2.5 million of
cash and cash equivalents and no debt. During the 2015 third quarter,
the Company paid a dividend to shareholders of $0.08 per share and did
not repurchase any shares of its common stock. Through its regular
quarterly dividend and the repurchase of common stock earlier in the
year, TransAct has returned $2.9 million to shareholders in the first
nine months of 2015.
Steve DeMartino, President and Chief Financial Officer of TransAct,
commented, “Our financial foundation remains sound and we are
well-positioned to capitalize on a number of exciting opportunities over
the remainder of 2015 and into 2016. We continue to generate strong free
cash flow, reflecting both solid top line growth and our success in
managing expenses. In particular, we have already exceeded our targeted
$1 million of annual cost savings and believe we can realize annualized
savings in excess of this target in the fourth quarter. Overall,
TransAct’s product portfolio and our continued investments to supplement
our existing products with new, high-margin offerings have us set up to
continue to drive shareholder value going forward.”
Summary of 2015 Third Quarter Operating Results
TransAct generated 2015 third quarter net sales of $14.2 million
compared with net sales of $13.4 million in the 2014 third quarter.
Casino and gaming revenue in the 2015 third quarter decreased 13% to
$4.4 million compared to $5.1 million in the prior year period as a 70%
year-over-year increase in sales of casino printers in the domestic
market was more than offset by a decline in international revenue. Food
safety, point-of-sale (POS) and banking revenue increased $0.8 million,
or 29%, to $3.4 million in the 2015 third quarter, including a 75%
year-over-year increase in sales of food safety terminals as well as
higher sales of the Company’s POS printer to McDonald’s. Lottery printer
sales for the 2015 third quarter were $1.8 million, compared with $1.5
million in the 2014 third quarter. Printrex® revenues were $0.2 million
in the 2015 third quarter compared to $1.0 million in the year-ago
quarter, and the Company’s TransAct Services Group recorded net sales of
$4.4 million, an increase of 37%, compared to $3.2 million in the
year-ago period on stronger sales of spare parts to its largest lottery
customer.
Gross margin increased to 44.4% in the third quarter of 2015 compared to
39.5% in the year-ago quarter, and gross profit rose 19% year over year
to $6.3 million primarily reflecting the higher revenue and the
continued shift in mix towards higher-margin products.
Total operating expenses for the 2015 third quarter were $4.7 million
compared to $5.2 million in the year-ago quarter. Excluding legal fees
related to the lawsuit with Avery Dennison Corporation in the prior-year
period, operating expenses declined 2% year over year reflecting the
Company’s successful execution of its cost reduction initiatives.
TransAct recorded operating income of $1.6 million, or 11.0% of net
sales, for the 2015 third quarter compared to $0.1 million, or 0.4% of
net sales, in the 2014 third quarter. Net income in the 2015 third
quarter was $1.0 million, or $0.13 per diluted share, compared to net
income of $0.1 million, or $0.01 per diluted share, in the prior-year
period.
2015 Third Quarter Conference Call and Webcast
TransAct is hosting a conference call and webcast today, November 5,
2015, beginning at 4:30 p.m. ET. Both the call and the webcast are open
to the general public. The conference call number is 678-825-8259
(domestic or international). Please call five minutes prior to the
presentation to ensure that you are connected.
Interested parties may also access the conference call live on the
Internet at www.transact-tech.com
(select “Investor Relations” followed by “Events & Presentations”).
Approximately two hours after the call has concluded, an archived
version of the webcast will be available for replay at the same location.
Non-GAAP Financial Measures
TransAct has provided adjusted non-GAAP financial measures because the
Company believes that these amounts are helpful to investors and others
to more accurately assess the ongoing nature of TransAct's core
operations. The adjusted non-GAAP measures exclude the effect in the
applicable periods presented of non-GAAP adjustments contained in the
tables included with this release. These items have been excluded from
adjusted non-GAAP financial measures as management does not believe that
they are representative of underlying trends in the Company's
performance. Their exclusion provides investors and others with
additional information to more readily assess the Company's operating
results. The Company uses the non-GAAP financial measures internally to
focus management on the results of the Company's core business. The
presentation of this additional non-GAAP information is not considered
superior to or a substitute for the financial information prepared in
accordance with GAAP.
Adjusted operating income is defined as operating income adjusted for
the impact of legal fees related to the lawsuit with Avery Dennison
Corporation and adjustments to accrued contingent consideration from the
Printrex acquisition.
Adjusted net income is defined as net income adjusted for the
tax-effected impact of legal fees related to the lawsuit with Avery
Dennison Corporation and adjustments to accrued contingent consideration
from the Printrex acquisition.
Adjusted diluted earnings per share is defined as adjusted net income
divided by diluted shares outstanding.
About TransAct Technologies Incorporated
TransAct Technologies Incorporated is a leader in developing and
manufacturing market-specific solutions, including printers, terminals,
software and other products for transaction-based and other industries.
These industries include casino and gaming, lottery, food safety,
banking, point-of-sale, hospitality, oil and gas, and medical and
mobile. TransAct printers and products are designed from the ground up
based on market-specific requirements and are sold under the AccuDate™,
Ithaca®, RESPONDER, Epic®, EPICENTRAL® and Printrex® product brands.
TransAct distributes its printers and terminals through OEMs,
value-added resellers, selected distributors, and direct to end-users.
TransAct has over 2.7 million printers and terminals installed around
the world. TransAct is also committed to providing world-class printer
service, spare parts, accessories and printing supplies to its worldwide
installed base of products. Through its TransAct Services Group,
TransAct provides a complete range of supplies and consumable items used
in the printing and scanning activities of customers in the hospitality,
banking, retail, gaming, government and oil and gas exploration markets.
Through its webstore, http://www.transactsupplies.com,
and a direct selling team, TransAct addresses the on-line demand for
these products. TransAct is headquartered in Hamden, CT. For more
information, please visit http://www.transact-tech.com
or call 203.859.6800.
Forward-Looking Statements
Certain statements in this press release include forward-looking
statements. Forward-looking statements generally can be identified by
the use of forward-looking terminology, such as "may", "will", "expect",
"intend", "estimate", "anticipate", "believe" or "continue" or the
negative thereof or other similar words. All forward-looking statements
involve risks and uncertainties, including, but not limited to, customer
acceptance and market share gains, both domestically and
internationally, in the face of substantial competition from competitors
that have broader lines of products and greater financial resources; our
competitors introducing new products into the marketplace; our ability
to successfully develop new products; our dependence on significant
customers; our dependence on significant vendors; dependence on contract
manufacturers for the assembly of a large portion of our products in
Asia; our ability to protect intellectual property; our ability to
recruit and retain quality employees as the Company grows; our
dependence on third parties for sales outside the United States,
including Australia, New Zealand, Europe, Latin America and Asia; the
economic and political conditions in the United States, Australia, New
Zealand, Europe, Latin America and Asia; marketplace acceptance of new
products; risks associated with foreign operations; the availability of
third-party components at reasonable prices; price wars or other
significant pricing pressures affecting the Company's products in the
United States or abroad; risks associated with potential future
acquisitions; our new line of food safety and oil and gas products
driving increased adoption by customers; and other risk factors detailed
from time to time in TransAct's reports filed with the Securities and
Exchange Commission. Actual results may differ materially from those
discussed in, or implied by, the forward-looking statements. The
forward-looking statements speak only as of the date of this release and
the Company assumes no duty to update them to reflect new, changing or
unanticipated events or circumstances.
|
TRANSACT TECHNOLOGIES INCORPORATED
|
CONSOLIDATED STATEMENTS OF INCOME
|
(Unaudited)
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
(In thousands, except per share amounts)
|
|
September 30,
|
|
September 30,
|
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
Net sales
|
|
$
|
14,172
|
|
$
|
13,389
|
|
$
|
47,560
|
|
$
|
40,812
|
Cost of sales
|
|
|
7,881
|
|
|
8,103
|
|
|
27,616
|
|
|
24,012
|
Gross profit
|
|
|
6,291
|
|
|
5,286
|
|
|
19,944
|
|
|
16,800
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
Engineering, design and product development
|
|
|
766
|
|
|
1,053
|
|
|
2,494
|
|
|
3,434
|
Selling and marketing
|
|
|
2,137
|
|
|
1,847
|
|
|
6,060
|
|
|
6,069
|
General and administrative
|
|
|
1,823
|
|
|
1,901
|
|
|
5,665
|
|
|
5,789
|
Legal fees and settlement expenses associated with lawsuit
|
|
|
-
|
|
|
428
|
|
|
1,738
|
|
|
475
|
|
|
|
4,726
|
|
|
5,229
|
|
|
15,957
|
|
|
15,767
|
Operating income
|
|
|
1,565
|
|
|
57
|
|
|
3,987
|
|
|
1,033
|
|
|
|
|
|
|
|
|
|
Interest and other income (expense):
|
|
|
|
|
|
|
|
|
Interest, net
|
|
|
(7)
|
|
|
(12)
|
|
|
(23)
|
|
|
(38)
|
Other, net
|
|
|
11
|
|
|
9
|
|
|
(1)
|
|
|
(11)
|
|
|
|
4
|
|
|
(3)
|
|
|
(24)
|
|
|
(49)
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
1,569
|
|
|
54
|
|
|
3,963
|
|
|
984
|
Income tax provision
|
|
|
541
|
|
|
4
|
|
|
1,403
|
|
|
365
|
Net income
|
|
$
|
1,028
|
|
$
|
50
|
|
$
|
2,560
|
|
$
|
619
|
|
|
|
|
|
|
|
|
|
Net income per common share:
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.13
|
|
$
|
0.01
|
|
$
|
0.33
|
|
$
|
0.07
|
Diluted
|
|
$
|
0.13
|
|
$
|
0.01
|
|
$
|
0.33
|
|
$
|
0.07
|
|
|
|
|
|
|
|
|
|
Shares used in per share calculation:
|
|
|
|
|
|
|
|
|
Basic
|
|
|
7,800
|
|
|
8,337
|
|
|
7,818
|
|
|
8,362
|
Diluted
|
|
|
7,848
|
|
|
8,403
|
|
|
7,844
|
|
|
8,487
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL INFORMATION – SALES BY SALES UNIT:
|
|
|
|
|
Three months ended
|
|
Nine months ended
|
|
|
|
September 30,
|
|
September 30,
|
|
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
Food safety, point-of-sale and banking
|
|
|
$
|
3,381
|
|
$
|
2,628
|
|
$
|
9,030
|
|
$
|
7,144
|
Casino and gaming
|
|
|
|
4,399
|
|
|
5,062
|
|
|
17,237
|
|
|
17,728
|
Lottery
|
|
|
|
1,797
|
|
|
1,473
|
|
|
8,767
|
|
|
3,143
|
Printrex
|
|
|
|
225
|
|
|
1,043
|
|
|
1,152
|
|
|
3,013
|
TransAct Services Group
|
|
|
|
4,370
|
|
|
3,183
|
|
|
11,374
|
|
|
9,784
|
Total net sales
|
|
|
$
|
14,172
|
|
$
|
13,389
|
|
$
|
47,560
|
|
$
|
40,812
|
|
|
|
|
|
|
|
|
|
|
|
TRANSACT TECHNOLOGIES INCORPORATED
|
CONSOLIDATED BALANCE SHEETS
|
(Unaudited)
|
|
|
|
|
|
|
|
September 30,
|
|
December 31,
|
(In thousands)
|
|
2015
|
|
2014
|
Assets:
|
|
|
|
|
Current assets:
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
2,450
|
|
$
|
3,131
|
Accounts receivable, net
|
|
|
9,937
|
|
|
9,094
|
Inventories
|
|
|
12,451
|
|
|
11,806
|
Deferred tax assets
|
|
|
1,822
|
|
|
3,068
|
Other current assets
|
|
|
494
|
|
|
898
|
Total current assets
|
|
|
27,154
|
|
|
27,997
|
|
|
|
|
|
Fixed assets, net
|
|
|
2,346
|
|
|
2,438
|
Goodwill
|
|
|
2,621
|
|
|
2,621
|
Deferred tax assets
|
|
|
1,113
|
|
|
1,068
|
Intangible assets, net
|
|
|
983
|
|
|
1,341
|
Other assets
|
|
|
23
|
|
|
26
|
|
|
|
7,086
|
|
|
7,494
|
Total assets
|
|
$
|
34,240
|
|
$
|
35,491
|
|
|
|
|
|
Liabilities and Shareholders’ Equity:
|
|
|
|
|
Current liabilities:
|
|
|
|
|
Accounts payable
|
|
$
|
5,459
|
|
$
|
2,365
|
Accrued liabilities
|
|
|
2,589
|
|
|
3,320
|
Income taxes payable
|
|
|
24
|
|
|
13
|
Accrued lawsuit settlement expenses
|
|
|
-
|
|
|
3,625
|
Deferred revenue
|
|
|
176
|
|
|
313
|
Total current liabilities
|
|
|
8,248
|
|
|
9,636
|
|
|
|
|
|
Deferred revenue, net of current portion
|
|
|
68
|
|
|
64
|
Deferred rent, net of current portion
|
|
|
112
|
|
|
172
|
Other liabilities
|
|
|
203
|
|
|
225
|
|
|
|
383
|
|
|
461
|
Total liabilities
|
|
|
8,631
|
|
|
10,097
|
|
|
|
|
|
Shareholders’ equity:
|
|
|
|
|
Common stock
|
|
|
111
|
|
|
111
|
Additional paid-in capital
|
|
|
28,709
|
|
|
28,167
|
Retained earnings
|
|
|
23,046
|
|
|
22,349
|
Accumulated other comprehensive loss, net of tax
|
|
|
(76)
|
|
|
(72)
|
Treasury stock, at cost
|
|
|
(26,181)
|
|
|
(25,161)
|
Total shareholders’ equity
|
|
|
25,609
|
|
|
25,394
|
Total liabilities and shareholders’ equity
|
|
$
|
34,240
|
|
$
|
35,491
|
|
|
TRANSACT TECHNOLOGIES INCORPORATED RECONCILIATION
OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING NON-GAAP
FINANCIAL MEASURES (Unaudited, thousands of dollars,
except percentages and per share amounts)
|
|
|
|
Three months ended September 30, 2015
|
|
|
Reported
|
|
Adjustments(1)
|
|
Adjusted Non-GAAP
|
Operating expenses
|
|
$
|
4,726
|
|
|
$
|
-
|
|
|
$
|
4,726
|
|
% of net sales
|
|
|
33.3
|
%
|
|
|
|
|
33.3
|
%
|
|
|
|
|
|
|
|
Operating income
|
|
|
1,565
|
|
|
|
-
|
|
|
|
1,565
|
|
% of net sales
|
|
|
11.0
|
%
|
|
|
|
|
11.0
|
%
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
1,569
|
|
|
|
-
|
|
|
|
1,569
|
|
Income tax provision
|
|
|
541
|
|
|
|
-
|
|
|
|
541
|
|
Net income
|
|
|
1,028
|
|
|
|
-
|
|
|
|
1,028
|
|
Diluted net income per share
|
|
$
|
0.13
|
|
|
$
|
-
|
|
|
$
|
0.13
|
|
|
|
|
|
|
|
|
(1) No adjustments.
|
|
|
|
|
|
|
|
|
|
Three months ended September 30, 2014
|
|
|
Reported
|
|
Adjustments (2)
|
|
Adjusted Non-GAAP
|
Operating expenses
|
|
$
|
5,229
|
|
|
|
($388
|
)
|
|
$
|
4,841
|
|
% of net sales
|
|
|
39.1
|
%
|
|
|
|
|
36.2
|
%
|
|
|
|
|
|
|
|
Operating income
|
|
|
57
|
|
|
|
388
|
|
|
|
445
|
|
% of net sales
|
|
|
0.4
|
%
|
|
|
|
|
3.3
|
%
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
54
|
|
|
|
388
|
|
|
|
442
|
|
Income tax provision
|
|
|
4
|
|
|
|
136
|
|
|
|
140
|
|
Net income
|
|
|
50
|
|
|
|
252
|
|
|
|
302
|
|
Diluted net income per share
|
|
$
|
0.01
|
|
|
$
|
0.03
|
|
|
$
|
0.04
|
|
|
|
|
|
(2)
|
|
Adjustment includes (i) $40 of income related to an adjustment to
accrued contingent consideration from the Printrex
acquisition and (ii) $428 of legal and other expenses related
to the lawsuit with Avery Dennison Corporation. Such adjustments
were tax effected using an effective tax rate of 35%.
|
|
|
|
|
|
|
|
|
TRANSACT TECHNOLOGIES INCORPORATED RECONCILIATION
OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING NON-GAAP
FINANCIAL MEASURES (Unaudited, thousands of dollars,
except percentages and per share amounts)
|
|
|
|
Nine months ended September 30, 2015
|
|
|
Reported
|
|
Adjustments(3)
|
|
Adjusted Non-GAAP
|
Operating expenses
|
|
$
|
15,957
|
|
|
$
|
(1,738
|
)
|
|
$
|
14,219
|
|
% of net sales
|
|
|
33.6
|
%
|
|
|
|
|
29.9
|
%
|
|
|
|
|
|
|
|
Operating income
|
|
|
3,987
|
|
|
|
1,738
|
|
|
|
5,725
|
|
% of net sales
|
|
|
8.4
|
%
|
|
|
|
|
12.0
|
%
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
3,963
|
|
|
|
1,738
|
|
|
|
5,701
|
|
Income tax provision
|
|
|
1,403
|
|
|
|
626
|
|
|
|
2,029
|
|
Net income
|
|
|
2,560
|
|
|
|
1,112
|
|
|
|
3,672
|
|
Diluted net income per share
|
|
$
|
0.33
|
|
|
$
|
0.14
|
|
|
$
|
0.47
|
|
|
|
|
|
(3)
|
|
Adjustments include $1,763 of legal and other expenses partially
offset by a $25 reversal of accrued settlement expenses
related to the lawsuit with Avery Dennison Corporation. Such
adjustments were tax effected using an effective tax rate of 36%.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended September 30, 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported
|
|
Adjustments (4)
|
|
Adjusted Non-GAAP
|
Operating expenses
|
|
|
|
|
|
|
|
|
|
|
|
$
|
15,767
|
|
|
$
|
(415
|
)
|
|
$
|
15,352
|
|
% of net sales
|
|
|
|
|
|
|
|
|
|
|
|
|
38.6
|
%
|
|
|
|
|
37.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
|
|
|
|
|
|
|
|
|
|
1,033
|
|
|
|
415
|
|
|
|
1,448
|
|
% of net sales
|
|
|
|
|
|
|
|
|
|
|
|
|
2.5
|
%
|
|
|
|
|
3.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
984
|
|
|
|
415
|
|
|
|
1,399
|
|
Income tax provision
|
|
|
|
|
|
|
|
|
|
|
|
|
365
|
|
|
|
145
|
|
|
|
510
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
619
|
|
|
|
270
|
|
|
|
889
|
|
Diluted net income per share
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.07
|
|
|
$
|
0.03
|
|
|
$
|
0.10
|
|
|
|
|
|
(4)
|
|
Adjustment includes (i) $60 of income related to an adjustment to
accrued contingent consideration from the Printrex
acquisition and (ii) $475 of legal and other expenses related
to the lawsuit with Avery Dennison Corporation. Such adjustments
were tax effected using an effective tax rate of 35%.
|
|
|
|
|
|
|
|
|
TRANSACT TECHNOLOGIES INCORPORATED RECONCILIATION
OF NET INCOME TO ADJUSTED EBITDA NON-GAAP FINANCIAL
MEASURES (Unaudited)
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
(In thousands)
|
|
September 30,
|
|
September 30,
|
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
Net income
|
|
$
|
1,028
|
|
$
|
50
|
|
|
$
|
2,560
|
|
$
|
619
|
|
|
|
|
|
|
|
|
|
|
Interest (income) expense, net
|
|
|
7
|
|
|
12
|
|
|
|
23
|
|
|
38
|
|
Income tax provision
|
|
|
541
|
|
|
4
|
|
|
|
1,403
|
|
|
365
|
|
Depreciation and amortization
|
|
|
343
|
|
|
357
|
|
|
|
1,077
|
|
|
1,084
|
|
|
|
|
|
|
|
|
|
|
EBITDA
|
|
|
1,919
|
|
|
423
|
|
|
|
5,063
|
|
|
2,106
|
|
|
|
|
|
|
|
|
|
|
Share-based compensation expense
|
|
|
108
|
|
|
133
|
|
|
|
377
|
|
|
442
|
|
Legal fees and settlement expenses associated with lawsuit
|
|
|
-
|
|
|
428
|
|
|
|
1,738
|
|
|
475
|
|
Adjustment to accrued contingent consideration
|
|
|
-
|
|
|
(40
|
)
|
|
|
-
|
|
|
(60
|
)
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA
|
|
$
|
2,027
|
|
$
|
944
|
|
|
$
|
7,178
|
|
$
|
2,963
|
|
|
|
|
|
|
|
|
|
|
![](http://cts.businesswire.com/ct/CT?id=bwnews&sty=20151105006393r1&sid=ntxv4&distro=nx&lang=en)
View source version on businesswire.com: http://www.businesswire.com/news/home/20151105006393/en/
Copyright Business Wire 2015